Ken Griffin Warns Deeply Triggering Inflation Still Hurting Americans on Everyday Items Israel Intensifies Strikes on Lebanon Expanding Ground Operations Beyond Security Zone Qualcomm Stock Surges as Investors Eye Potential in AI Device Boom MENA Leaders Advocate Holistic Housing Policy at Baku Forum Beyond Construction to Livelihoods and Climate Artificial Intelligence Reshapes Investment Management Deloitte Highlights Transformative Potential Consumer Sentiment Drops to Record Low in Early May as Iran War Drives Gas Prices Higher BWX Technologies Q1 2026 Earnings EPS Surges Past Estimates as Nuclear Backlog Strengthens AMPY Q1 2026 Earnings Significant EPS Miss Highlights Operational Challenges Viking Holdings VIK Q1 2026 Earnings NarrowerThanExpected Loss Amid Solid Booking Momentum MATW Q1 2026 Earnings Stellar EPS Surprise Lifts Investor Sentiment Cartesian Therapeutics RNAC Q1 2026 Earnings WiderThanAnticipated Loss Masks Progress in CART Pipeline STRZ Q1 2026 Earnings Massive EPS Miss Sends Mixed Signals as Stock Rises ITHAW Warrants Hold Steady at 024 as ITHAX Acquisition Corp III Nears Resistance T Rowe Price Group Inc TROW Edges Higher as Shares Test Resistance LightPath Technologies Surges 13 as Momentum Builds Key Levels to Watch Churchill Downs CHDN Holds Steady Near Support After Minimal Decline Salesforce CRM Edges Higher as Investors Eye Cloud Growth and Key Resistance Barclays Upgrades Transocean RIG to Overweight A Bullish Signal for Offshore Drilling GAINN Q1 2026 Earnings EPS Misses Estimates as Net Investment Income Declines Ascent Solar Technologies ASTI Surges 12 as Momentum Builds Above Key Support ASND Q1 2026 Earnings WiderthanExpected Loss Sends Shares Lower Contineum Therapeutics Inc CTNM Q1 2026 Earnings Narrower Loss Beats Expectations ENVA Q1 2026 Earnings EPS Beats Estimates by 335 as Shares Dip SKM Q4 2025 Earnings EPS Misses Estimates Stock Declines MediaAlpha MAX Q1 2026 Earnings EPS Misses Estimates Despite Modest Stock Gain Traws Pharma Inc TRAW Q1 2026 Earnings Narrower Net Loss Beats Estimates as Clinical Pipeline Advances UMBFO Q1 2026 Earnings Strong EPS Beat Signals Resilience Despite Revenue Disclosure Gap